Contraception News and Research

Latest Contraception News and Research

Employers worry they'll pay bill for those exempt from contraceptive mandate

Businesses are concerned that non-religious employers will end up covering the bill for religious groups that refuse to pay for contraception for their employees. Meanwhile, church leaders continue their push to broaden the exemption from the contraception coverage rule.

4 Jul 2013

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Last week saw two major developments in the legal and political battle over the Obama administration's sound decision to require most employers to provide free insurance coverage of contraceptives for women under the new health care law -; one of them positive and the other a blow to the mandate and to religious liberty (7/1).

3 Jul 2013

Viewpoints: A 'clever' fix for contraception coverage; Sanjay Gupta warns doctors to pay attention to health overhaul

Many nonprofit religious organizations have balked at having to insure their employees' birth control -- because they don't believe in artificial contraception -- under the Affordable Care Act. On Friday, the Obama administration announced a solution to this problem. The new health care law guarantees access to preventive services, and contraception falls, appropriately, into that category (Carla Hill, 6/28).

2 Jul 2013

Contraceptive exemption for religious groups finalized

The rule, issued under the health care law, attempts to quell the controversy by balancing the interests of women with the concerns of the Roman Catholic Church and other employers with religious objections to providing coverage for contraceptives.

2 Jul 2013

First Edition: July 1, 2013

Today's headlines include a variety of weekend news reports, including coverage of the Obama administration's final contraceptive coverage rule as well as a range of other stories on health law implementation issues.

1 Jul 2013

Appeals court green lights Hobby Lobby's legal challenge to contraceptive coverage rule

A federal appeals court in Denver said Thursday that companies, whether they are for profit or not, have religious rights and that the challenge brought by Hobby Lobby Stores Inc. and its sister company can go forward.

29 Jun 2013

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

Genzyme, a Sanofi company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for approval of LEMTRADA (alemtuzumab) for the treatment of adult patients with relapsing remitting multiple sclerosis with active disease defined by clinical or imaging features.

28 Jun 2013

First Edition: June 28, 2013

Today's headlines include reports that the high court sent a tentative signal Thursday that it was moving toward hearing a case on the regulation of abortion-inducing drugs.

28 Jun 2013

Florida firm gets religious reprieve from health law's contraception coverage rule; W.Va. auto dealer seeks relief

An update on employers' legal challenges to the provisions requiring contraceptive coverage.

28 Jun 2013

European regulators grant CE Mark approval for single-size SILCS Diaphragm

Soon, women in Europe may be taking a new look at one of the world's oldest forms of contraception. European regulators have granted the single-size SILCS Diaphragm a CE marking, allowing the product to be sold throughout Europe. The launch is also an important step toward expanding nonhormonal contraception options for women worldwide.

21 Jun 2013

European Commission amends marketing authorisation for Celgene's REVLIMID

Celgene International Sàrl was today notified that the European Commission has amended the marketing authorisation for REVLIMID. This decision means that REVLIMID is now approved to treat patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.

17 Jun 2013

Complications emerge to administration's Plan B proposal

NPR reports on Judge Edward Korman's response to the Obama administration's Plan B proposal while CNN Money explores how the "conscience clause" creates challenges for drugstores as they sell the morning-after pill over the counter.

15 Jun 2013

Judge OKs administration plan on 'morning after' pill

A federal judge Wednesday accepted the Obama administration's plan to make the Plan B One-Step "morning after pill" available over the counter to buyers of all ages, winding down a decade-long fight over the pill.

14 Jun 2013

Xgeva receives FDA approval for treating giant cell tumor of the bone

The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone, a rare and usually non-cancerous tumor.

14 Jun 2013

Questions emerge as dust settles surrounding Plan B policy change

News outlets offer day-after coverage of the Obama administration's reversal on the morning-after contraceptive pill.

13 Jun 2013

First Edition: June 13, 2013

Today's headlines include reports about how employers are preparing for some parts of the health law to kick in.

13 Jun 2013

Viewpoints: Administration 'finally' comes around on Plan B; 'Legal loophole' creates another compounded drug scare

Reluctantly yielding to a federal-court decision, the Obama administration announced on Monday that it will take steps to allow a version of the so-called morning-after pill, known as Plan B One-Step, to be sold over the counter to girls and women of all ages. They will not need a prescription, nor will they be required to show any identification to obtain the emergency contraceptive. There will be no restrictions on where the drug can be sold; it will be up to the manufacturer to propose appropriate venues (6/11).

13 Jun 2013

First Edition: June 12, 2013

Today's headlines include reports about how the health law's implementation played in a recent town hall meeting as well as the action taken by one business in anticipation of its some of the requirements that will take effect in 2014.

12 Jun 2013

Viewpoints: Medicaid expansion 'makes sense'; Budget cuts hurt Alzheimer's research; Lack of transparency in generic Rx prices

The numbers in the Rand study ... should not be a surprise to people who have been paying attention. Numerous studies now, including in Missouri, have pointed to the simple reality of the policy implications of the ACA to argue for Medicaid expansion.

12 Jun 2013

Obama administration changes course on Plan B

Monday afternoon, the Justice Department announced it would accept recent court rulings and begin putting into effect a judge's order to have the Food and Drug Administration certify the Plan B pill for use without prescription and without age restrictions on sales.

12 Jun 2013

Contraception News and Research

Latest Contraception News and Research

Employers worry they'll pay bill for those exempt from contraceptive mandate

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Viewpoints: A 'clever' fix for contraception coverage; Sanjay Gupta warns doctors to pay attention to health overhaul

Contraceptive exemption for religious groups finalized

First Edition: July 1, 2013

Appeals court green lights Hobby Lobby's legal challenge to contraceptive coverage rule

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

First Edition: June 28, 2013

Florida firm gets religious reprieve from health law's contraception coverage rule; W.Va. auto dealer seeks relief

European regulators grant CE Mark approval for single-size SILCS Diaphragm

European Commission amends marketing authorisation for Celgene's REVLIMID

Complications emerge to administration's Plan B proposal

Judge OKs administration plan on 'morning after' pill

Xgeva receives FDA approval for treating giant cell tumor of the bone

Questions emerge as dust settles surrounding Plan B policy change

First Edition: June 13, 2013

Viewpoints: Administration 'finally' comes around on Plan B; 'Legal loophole' creates another compounded drug scare

First Edition: June 12, 2013

Viewpoints: Medicaid expansion 'makes sense'; Budget cuts hurt Alzheimer's research; Lack of transparency in generic Rx prices

Obama administration changes course on Plan B

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Contraception News and Research

Latest Contraception News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in